Inaktiver Wert

Andere Sprachen Orchard Therapeutics plc

Aktien

A3D7B8

US68570P2002

ORTX

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Orchard Therapeutics Announces Multiple Presentations at ASGCT 2024	07.05.
Orchard Therapeutics Co-founder and Chief Executive Officer Dr. Bobby Gaspar Named to Inaugural 2024 TIME100 Health List	06.05.
Orchard Therapeutics Co-founder and Chief Executive Officer Dr. Bobby Gaspar Named to Inaugural 2024 TIME100 Health List	03.05.
FDA Approves First Gene Therapy To Treat Children With Metachromatic Leukodystrophy	03.04.
FDA approves innovative gene therapy for MLD	20.03.
Orchard Therapeutics Outlines U.S. Launch Plans for Lenmeldy™ (atidarsagene autotemcel), the Only Approved Therapy for Children with Early-onset Metachromatic Leukodystrophy	20.03.
Orchard Therapeutics Receives FDA Approval of Lenmeldy™ (atidarsagene autotemcel), the Only Therapy for Eligible Children with Early-onset Metachromatic Leukodystrophy in the U.S.	18.03.
Orchard Therapeutics Receives FDA Approval of Lenmeldy? (atidarsagene autotemcel)	18.03.
Orchard Therapeutics Announces First Patient Randomized in Registrational Trial of OTL-203 for MPS-I Hurler Syndrome	05.02.
Orchard Therapeutics Announces First Patient Randomized in Registrational Trial of OTL-203 for MPS-I Hurler Syndrome	05.02.
Orchard Therapeutics Announces Multiple Presentations at the 20th Annual WORLDSymposium	02.02.
Kyowa Kirin Co., Ltd - Notice regarding Completion of Share Acquisition of Orchard Therapeutics plc	26.01.
Japanese Shares Skid as Inflation Slows Faster-than-Expected in January	26.01.
Kyowa Kirin Acquires All Outstanding Shares of Orchard Therapeutics	26.01.
Orchard Therapeutics Announces Agreement with the Beneluxa Consortium Enabling Reimbursed Access to Libmeldy	25.01.
Orchard Therapeutics plc Announces Board Changes	24.01.
Orchard Therapeutics Completes Sale to Japan's Kyowa Kirin	24.01.
Kyowa Kirin successfully completes acquisition of Orchard Therapeutics, a global gene therapy leader for rare diseases	24.01.
Orchard Therapeutics plc(NasdaqCM:ORTX) dropped from NASDAQ Composite Index	24.01.
Kyowa Kirin Co., Ltd. completed the acquisition of Orchard Therapeutics plc from RA Capital Management, L.P., Deep Track Capital, LP, Zentree Investment Management Pte. Ltd. and others.	24.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Orchard Therapeutics plc

Aktien

A3D7B8

US68570P2002

ORTX

Andere Sprachen

Filter